Lilly ' s Bebtelovimab Receives Emergency Use Authorization for the Treatment of Mild-to-Moderate COVID-19

INDIANAPOLIS, Feb. 11, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates neutralization against the Omicron variant, Eli Lilly and...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials